The FDA’s March 2013 notice and an abstract of the NEJM study about azithromycin are available at the following links:
- FDA Drug Safety Communication: Azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms, U.S. Food and Drug Administration
- Azithromycin and the Risk of Cardiovascular Death, The New England Journal of Medicine
You should also contact The Driscoll Firm at our toll-free number or through our online form to speak with an azithromycin heart risk attorney.